|
Real-time Estimate
Cboe BZX
17:34:24 19/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.940 USD | +3.12% |
|
-9.42% | -35.90% |
| 10-14 | Stifel Initiates Immatics at Buy With $15 Price Target | MT |
| 10-02 | Nanobiotix Names New Finance Chief | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 920M | - | ||||
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
